Literature DB >> 22752800

Surgical technique: Unicondylar osteoallograft prosthesis composite in tumor limb salvage surgery.

Hongbin Fan1, Zheng Guo, Zhen Wang, Jing Li, Xiangdong Li.   

Abstract

BACKGROUND: After resecting tumors confined to one femoral condyle, a unicondylar osteoarticular allograft can be used for reconstruction without sacrificing the uninvolved condyle. However, unicondylar osteoarticular allografts have been associated with a high rate of joint degeneration. We describe a unicondylar osteoallograft prosthesis composite reconstruction replacing only one side of the joint to reduce compartment degeneration and avoid contamination of the tibia, but the survival, function, and complications of a unicondylar osteoallograft prosthesis composite are unclear. DESCRIPTION OF TECHNIQUE: We located a bone resection plane intraoperatively as planned before surgery using a computer-assisted navigation system. The tumor then was removed en bloc and the unicondylar defect filled with a size-matched allogeneic unicondyle. The allograft cartilage was removed. Thereafter, the condyle of the femoral component was resurfaced with a unicompartmental knee prosthesis to form a unicondylar osteoallograft prosthesis composite, however the tibia was left undisturbed. Navigation allowed precise apposition between the unicondylar osteoallograft prosthesis composite and host bone to ensure mechanical alignment and congruency of the joint surface before fixation with a plate.
METHODS: We retrospectively reviewed 12 patients who underwent unicondylar osteoallograft prosthesis composite reconstructions after unicondylar resection for tumors. One patient died from tumor-related causes without unicondylar osteoallograft prosthesis composite failure after 18 months. We observed the survival rate of unicondylar osteoallograft prosthesis composite reconstruction and related complications. Function and radiographs also were documented according to the Musculoskeletal Tumor Society (MSTS) functional scoring system and the International Society of Limb Salvage radiographic scoring system. The minimum followup was 8 months (median, 37 months; range, 8-65 months).
RESULTS: At last followup, 10 of the 12 unicondylar osteoallograft prosthesis composite reconstructions were still in place. Three reconstructions failed owing to two local recurrences (both treated with amputation) and there was one infection (treated with revision and maintenance of the implant at last followup). The average MSTS functional score at last followup was 27 points and the radiographic score 91%.
CONCLUSIONS: Our observations suggest unicondylar osteoallograft prosthesis composite reconstruction might be a reliable technique with relatively few major complications and at least short-term maintenance of the tibial cartilage. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2012        PMID: 22752800      PMCID: PMC3492634          DOI: 10.1007/s11999-012-2455-8

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  22 in total

1.  Precision tumour resection and reconstruction using image-guided computer navigation.

Authors:  K C Wong; S M Kumta; K H Chiu; G E Antonio; P Unwin; K S Leung
Journal:  J Bone Joint Surg Br       Date:  2007-07

2.  Survival of total knee replacement with a megaprosthesis after bone tumor resection.

Authors:  David Biau; Florent Faure; Sandrine Katsahian; Cécile Jeanrot; Bernard Tomeno; Philippe Anract
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

3.  Fresh osteochondral allografts for posttraumatic knee defects: long-term followup.

Authors:  A E Gross; W Kim; F Las Heras; D Backstein; O Safir; K P H Pritzker
Journal:  Clin Orthop Relat Res       Date:  2008-05-09       Impact factor: 4.176

4.  Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur. Medium to long-term results.

Authors:  A Kawai; G F Muschler; J M Lane; J C Otis; J H Healey
Journal:  J Bone Joint Surg Am       Date:  1998-05       Impact factor: 5.284

5.  Patellar reconstruction of the condyles in giant cell tumours of the knee.

Authors:  M Farooque; R K Sharma
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

6.  Autogenous patella as replacement for a resected femoral or tibial condyle. A report on 19 cases.

Authors:  M Campanacci; C Cervellati; U Donati
Journal:  J Bone Joint Surg Br       Date:  1985-08

7.  Use of distal femoral osteoarticular allografts in limb salvage surgery.

Authors:  D Luis Muscolo; Miguel A Ayerza; Luis A Aponte-Tinao; Maximiliano Ranalletta
Journal:  J Bone Joint Surg Am       Date:  2005-11       Impact factor: 5.284

8.  Giant-cell tumor of bone.

Authors:  M Campanacci; N Baldini; S Boriani; A Sudanese
Journal:  J Bone Joint Surg Am       Date:  1987-01       Impact factor: 5.284

9.  Unicondylar osteoarticular allografts of the knee.

Authors:  D Luis Muscolo; Miguel A Ayerza; Luis A Aponte-Tinao; Eduardo Abalo; German Farfalli
Journal:  J Bone Joint Surg Am       Date:  2007-10       Impact factor: 5.284

10.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

View more
  12 in total

1.  Techniques in surgical navigation of extremity tumors: state of the art.

Authors:  Luis A Aponte-Tinao; Lucas E Ritacco; Federico E Milano; Miguel A Ayerza; German F Farfalli
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

2.  Three-dimensional virtual bone bank system for selecting massive bone allograft in orthopaedic oncology.

Authors:  Zhigang Wu; Jun Fu; Zhen Wang; Xiangdong Li; Jing Li; Yanjun Pei; Guoxian Pei; Dan Li; Zheng Guo; Hongbin Fan
Journal:  Int Orthop       Date:  2015-03-15       Impact factor: 3.075

3.  Surgical technique: Unicondylar osteoallograft prosthesis composite in tumor limb salvage surgery.

Authors:  Markus Nottrott; Jendrik Hardes; Georg Gosheger; Arne Streitbürger
Journal:  Clin Orthop Relat Res       Date:  2013-04-04       Impact factor: 4.176

4.  Reply to letter to the editor: Surgical technique: Unicondylar osteoallograft prosthesis composite in tumor limb salvage surgery.

Authors:  Hongbin Fan; Zheng Guo; Zhen Wang; Jing Li; Xiangdong Li
Journal:  Clin Orthop Relat Res       Date:  2013-04-04       Impact factor: 4.176

5.  Does intraoperative navigation assistance improve bone tumor resection and allograft reconstruction results?

Authors:  Luis Aponte-Tinao; Lucas E Ritacco; Miguel A Ayerza; D Luis Muscolo; Jose I Albergo; Germán L Farfalli; Germán L Farfall
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

Review 6.  The evolution of three-dimensional technology in musculoskeletal oncology.

Authors:  Vishaal Nanik Thadani; Muhammad Jahangir Riaz; Gurpal Singh
Journal:  J Clin Orthop Trauma       Date:  2018-07-25

7.  The value of computer-assisted navigation for bone reconstruction after tumor resection.

Authors:  Xuejun Peng; Fengping Wang; Jing Su
Journal:  Oncol Lett       Date:  2017-07-05       Impact factor: 2.967

8.  Surgical management of pelvic Ewing's sarcoma in children and adolescents.

Authors:  Hongbin Fan; Zheng Guo; Jun Fu; Xiangdong Li; Jing Li; Zhen Wang
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

Review 9.  Implantation of customized 3-D printed titanium prosthesis in limb salvage surgery: a case series and review of the literature.

Authors:  Hongbin Fan; Jun Fu; Xiangdong Li; Yanjun Pei; Xiaokang Li; Guoxian Pei; Zheng Guo
Journal:  World J Surg Oncol       Date:  2015-11-04       Impact factor: 2.754

10.  Navigation in Musculoskeletal Oncology: An Overview.

Authors:  Guy Vernon Morris; Jonathan D Stevenson; Scott Evans; Michael C Parry; Lee Jeys
Journal:  Indian J Orthop       Date:  2018 Jan-Feb       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.